InsidersTradesSigma
Follow the 爱博医疗 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 爱博医疗 has logged 5 public disclosures. Market capitalisation: €7.7bn. The latest transaction was filed on 26 June 2025 (Purchase). Among the most active insiders: 王曌. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€209,924
5 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,291 of 29,063 companies
58.8
score / 100
Value47
Quality71
FCF yld3.2%
Earn yld3.5%
EV/EBITDA17.3x
ROE8.2%
Gross mgn63%
Net mgn18%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 June 2025
Declarations5 total
5 of 5 declarations
关于 爱博医疗
爱博医疗是一家专注于医疗保健和制药领域的公司，在 XSHG 市场上市。它致力于创新医疗产品的开发和商业化。